Literature DB >> 6298956

Chikungunya virus infection. A retrospective study of 107 cases.

S W Brighton, O W Prozesky, A L de la Harpe.   

Abstract

A retrospective study of 107 cases of serologically proven chikungunya (CHIK) virus infection was undertaken. All respondents had contracted the disease at least 3 years previously; 87,9% had fully recovered, 3,7% experienced only occasional stiffness or mild discomfort, 2,8% had persistent residual joint stiffness but no pain, while 5,6% had persistent joint pain and stiffness and frequent effusions. Synovial fluid from 3 patients was analysed. All the patients with persistent joint pain and stiffness had very high antibody titres against CHIK virus.

Entities:  

Mesh:

Year:  1983        PMID: 6298956

Source DB:  PubMed          Journal:  S Afr Med J


  83 in total

1.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness.

Authors:  Daniel Ciampi de Andrade; Sylvain Jean; Pierre Clavelou; Radhouane Dallel; Didier Bouhassira
Journal:  BMC Infect Dis       Date:  2010-02-19       Impact factor: 3.090

3.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.

Authors:  Vinod Ravindran; George Alias
Journal:  Clin Rheumatol       Date:  2016-10-04       Impact factor: 2.980

5.  A destructive arthropathy following Chikungunya virus arthritis--a possible association.

Authors:  S W Brighton; I W Simson
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

6.  Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic.

Authors:  Alladi Mohan; D H N Kiran; I Chiranjeevi Manohar; D Prabath Kumar
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

7.  Persisting mixed cryoglobulinemia in Chikungunya infection.

Authors:  Manuela Oliver; Marc Grandadam; Catherine Marimoutou; Christophe Rogier; Elisabeth Botelho-Nevers; Hugues Tolou; Jean-Luc Moalic; Philippe Kraemer; Marc Morillon; Jean-Jacques Morand; Pierre Jeandel; Philippe Parola; Fabrice Simon
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03

8.  Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study.

Authors:  Man-Koumba Soumahoro; Patrick Gérardin; Pierre-Yves Boëlle; Joelle Perrau; Adrian Fianu; Jacques Pouchot; Denis Malvy; Antoine Flahault; François Favier; Thomas Hanslik
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

9.  Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak.

Authors:  Frederik Staikowsky; François Talarmin; Philippe Grivard; Abdel Souab; Isabelle Schuffenecker; Karin Le Roux; Marc Lecuit; Alain Michault
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

10.  Guillain-Barré syndrome after chikungunya infection.

Authors:  Gaëtan Lebrun; Karim Chadda; Anne-Hélène Reboux; Olivier Martinet; Bernard-Alex Gaüzère
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.